Molecular Diagnostics Market Growth

Rise in Infectious and Chronic Diseases to Drive Molecular Diagnostics Market Growth; Revenue to Cross US$ 30.9 billion by 2035 | Roots Analysis

According to a recently published report by Roots Analysis, the growing demand for personalized healthcare and the increasing prevalence of chronic disorders are driving the molecular diagnostics market growth 

Molecular Diagnostics Market Overview

The global Molecular Diagnostics Market size is estimated to grow at an annualized growth rate of 6.2% during the forecast period 2024-2035 and is expected to reach over USD 30.9 billion by 2035.  

Molecular diagnostic solutions have revolutionized healthcare by their ability to offer precise diagnostics and to enable early interventions to investigate the human, viral, and microbial genomes. Further, given the benefits offered by such diagnostic solutions, such as providing rapid diagnostic results and improving patient outcomes, the market is expected to grow at a healthy compounded annual growth rate (CAGR) during the forecast period.

Browse 130+ figures and 150+ market data tables spread across 220+ pages and detailed table of contents on “Molecular Diagnostics Market: Industry Trends and Global Forecasts, till 2035 by Test Type, Type of Offering, Type of Sample, Type of Technology, Therapeutic Area, End Users and Geographical Regions” here  https://www.rootsanalysis.com/reports/molecular-diagnostics-market.html

Market Drivers

Several factors are contributing to the growth of the molecular diagnostics market. Firstly, the increasing prevalence of chronic and infectious diseases has driven the demand for molecular diagnostic solutions and services. Further, PCR tests, next generation sequencing technologies and microarrays are expected to gain significant traction in the coming period. The ability of such solutions to enhance accuracy and speed of diagnosis enables healthcare providers to make informed diagnostic decisions. In addition, the rise in ageing population is anticipated to drive the market forward, as older individuals typically have an increased need for intensive healthcare services which tend to be capital extensive.

Market Restraints

Market restraints are the factors or conditions that can limit the growth and progress of a market. While the molecular diagnostics market is experiencing substantial growth, it is not without its challenges. One of the primary restraints is the stringent regulatory requirements for the approval of such products. The molecular diagnostic solutions require compliance of stringent regulatory frameworks, such as FDA approval and CE marking. These frameworks impose strict requirements on the development, validation, and commercialization which requires significant time, resources, and expertise in this domain. Furthermore, setting up molecular diagnostic facilities requires significant capital and operational expenditure. In addition, diagnostic centers performing such tests need high expenditure, as the instruments required to perform such tests tend to be expensive and require significant expenses in order to navigate through regulatory approvals.

Growth Factors

Despite the challenges, several growth factors are propelling the growth of the molecular diagnostics market. Primarily, there are a number of strategic collaborations and partnerships that have been signed between molecular diagnostic manufacturers, diagnostic centers, and research institutions which aim to foster innovation and accelerate the development and adoption of new diagnostic technologies. In addition, the growth of point-of-care testing and at-home testing have significantly expanded the molecular diagnostic market. Owing to their ability to provide rapid testing, reducing turnaround times and enabling quicker decision-making, such solutions drive the demand for innovative diagnostic solutions, fueling the molecular diagnostics market growth.

Molecular Diagnostics Market Segments

Based on test type, the market is segmented into laboratory and point-of-care testing

• The laboratory testing segment led the molecular diagnostics market, capturing the largest revenue share of 85% in 2024.
• The point-of-care segment is anticipated to show the highest annual growth rate of 9.1% during the forecast period.

Based on the type of offering, the market is segmented into reagents, instruments, and services

• The reagents segment led the molecular diagnostics market, capturing the largest revenue share of 70% in 2024.
• Owing to the intricacies and complexities associated with the development of molecular diagnostic solutions, this trend is expected to remain the same during the forecast period.

Based on the type of sample, the market is segmented into blood / serum / plasma, urine, and other samples

• The blood, serum and plasma segment led the molecular diagnostics market, capturing the largest revenue share of 77% in 2024.
• The urine segment is anticipated to show the highest annual growth rate of 7.0% during the forecast period.

Based on type of technology, the market is segmented into PCR, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, microarrays, mass spectrometry and others

• The PCR technology segment led the molecular diagnostics market, capturing the largest revenue share of 41% in 2024.
• The next generation sequencing is anticipated to show the highest annual growth rate of 7.3% during the forecast period.

Based on therapeutic areas, the market is segmented into cardiovascular diseases, genetic diseases, infectious diseases, neurological diseases, oncological disorders and others

• The infectious disease segment led the molecular diagnostics market, capturing the largest revenue share of 42.8% in 2024.
• The neurological segment is anticipated to show the highest annual growth rate of 6.9%, during the forecast period.

Based on end users, the market is segmented into hospitals, laboratories, and other end users

• The hospitals segment led the molecular diagnostics market, capturing the largest revenue share of 48% in 2024.
• The hospitals segment is anticipated to show an annual growth rate of 6.5% during the forecast period and is expected to hold the majority share of the market in the future, as well.

Based on geographical regions, the market is segmented into North America, Europe, Asia, Latin America, Middle East and North Africa, and Rest of the World

• North America dominated the molecular diagnostics market and accounted for the largest revenue share of 38.9 % in 2024.
• In Asia, the molecular diagnostics market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The molecular diagnostics market report also includes detailed profiles of key players (listed below) that offer such solutions:

• Abbott
• Agilent Technologies
• Becton Dickinson
• BGI Genomics
• bioMérieux
• Bio-Rad
• Danaher
• DiaSorin
• Grifols
• Hologic
• Illumina
• Qiagen
• QuidelOrtho
• Revvity
• Roche
• Sansure
• Seegene
• Siemens Healthineers
• Sysmex
• Thermo Fisher Scientific

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/molecular-diagnostics-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com